参附注射液治疗慢性心力衰竭临床疗效分析

目的对参附注射液治疗慢性心力衰竭(CHF)的临床疗效进行分析。方法将72例心力衰竭患者随机分为治疗组和对照组,对照组给予常规西医治疗,使用血管紧张素转换酶抑制剂、β-受体阻滞剂、洋地黄制剂、利尿剂、硝酸酯制剂等,治疗组在对照组治疗的基础上,加用参附注射液50 mL+5%葡萄糖注射液100 mL中,静滴,1次/d,14 d为1个疗程。结果治疗组慢性心力衰竭患者应用参附注射液后,有效率为94.44%,对照组有效率为83.33%,治疗组总有效率明显优于对照组(P<0 05);而治疗组的心功能改善也明显优于对照组(P<0 05)。结论慢性心力衰竭在常规治疗基础上,加用参附注射液的治疗具有更满意的临床疗效,未发现不良反应,值得临床推广。

Effect of Shenfu Injection in the Treatment of Chronic Heart Failure

Objective The effect of Shenfu Injection in treatment of chronic heart failure(CHF) clinical analysis.Methods 72 cases of heart failure patients were randomly divided into treatment group and control group.The control group received routine given western medicine treatment,the use of angiotensin-converting enzyme inhibitors,beta-blockers,digitalis,diuretics,nitrate preparations,the treatment group in the control group on the basis of the treatment combined with Shenfu Injection in 5% glucose injection 50 mL,100 mL IV drip,1 times a day.14 d 1 treatment.Results The effective rate of treatment group was 94.44% and control group was 83.33%,total effective rate in the treatment group was significantly better than the control group.(P<0.05);while the treatment group improved cardiac function was significantly better than the control group(P<0.05).Conclusion Chronic heart failure on the basis of conventional therapy plus Shenfu injection treatment has more satisfactory curative effect,no adverse reactions.It is worthy of clinical application.